Hoʻoponopono Hoʻokō (EU) 2022/801 o ke Komisina, o 20




ʻO ke Kānāwai Kūkākūkā

hōʻuluʻulu manaʻo

KOMISINA Eulopa,

No ka pili ana i ke Kuikahi no ka hana ana o ka Hui Europa,

E noʻonoʻo ana i ka Hoʻoponopono (CE) n. 1107/2009 o ka European Parliament a me ka Council, o ʻOkakopa 21, 2009, e pili ana i ke kūʻai aku ʻana i nā huahana pale mea kanu a me nā Directives 79/117/CEE a me 91/414/CEE o ka ʻaha kūkā e hoʻopau ʻia (1), a e pili ana i ka pauku 78, pauku 2,

E noʻonoʻo ana i kēia mau mea:

  • (1) Ma ka ʻāpana A o ka hoʻohui i ka Implementing Regulation (EU) no. 540/2011 o ke Komisina (2) papa inoa i nā mea ikaika i hoʻokomo mua ʻia ma Annex I o ka Council Directive 91/414/EEC (3) a ua manaʻo ʻia i ʻae ʻia e like me Regulation (EC) No. 1107/2009. He 354 mau mea hana i ka mua.
  • (2) E pili ana i ka 68 o nā mea hana ma ka ʻāpana A o ka annex to Implementing Regulation (EU) no. 540/2011 ʻaʻole i waiho ʻia nā palapala hoʻohou, ua waiho ʻia akā ua hoʻihoʻi ʻia, me ka hopena o ka pau ʻana o nā manawa ʻae o kēia mau mea hana.
  • (3) Ma ka ʻāpana B o ka hoʻohui i ka Implementing Regulation (EU) no. 540/2011 papa inoa i nā mea hana i ʻae ʻia e like me ka Regulation (EC) no. 1107/2009. No 7 o ia mau mea hooikaika, aole i waihoia mai he palapala noi hou i ekolu makahiki ma mua o ka pau ana o ko lakou mau apono ana, ua waihoia aka ua hoopau ia, me ka hopena o ka pau ana o na manawa apono no keia mau mea ikaika.
  • (4) No ka maopopo a me ka maopopo, ua kūpono i nā mea a pau i ʻae ʻole ʻia a i manaʻo ʻia i ʻae ʻia ma hope o ka pau ʻana o kahi manawa apono i hōʻike ʻia no lākou ma ka Māhele A a i ʻole ka Māhele B o ka Annex to the Regulation of Execution ( EU) n. Wehe ʻia ʻo 540/2011 mai ka ʻāpana A a i ʻole ka ʻāpana B, e like me ka hihia, o ka hoʻohui i ka Regulation (EU) no. 540/2011.
  • (5) No laila, ke kaʻina hana o ka hoʻololi ʻana i ka Hoʻoponopono Hoʻokō (EU) n. 540/2011 e like me ia.
  • (6) ʻO nā ana i hāʻawi ʻia i loko o kēia Hoʻoponopono e like me ka manaʻo o ke Komite Kū i nā mea kanu, nā holoholona, ​​​​nā meaʻai a me nā meaʻai,

Ua hoʻokō i kēia mau kānāwai:

Paukū 1

ʻO ka hoʻohui i ka Hoʻoponopono Hoʻokō (EU) n. Hoʻololi ʻia ʻo 540/2011 e like me nā ʻōlelo o ka annex i kēia Regulation.

Artículo 2

E hoʻomaka ana kēia Hoʻoponopono i nā lā he iwakālua ma hope o kona paʻi ʻia ʻana ma ka Official Journal of the European Union.

E hoʻopaʻa ʻia kēia Hoʻoponopono i nā mea āpau a pili pono i kēlā me kēia Moku'āina lālā.

Hana ʻia ma Brussels, ma Mei 20, 2022.
No ke Komisina
ka peresidena
Ursula VON DER LEYEN

MEA MAHIAI

ʻO ka hoʻohui i ka Hoʻoponopono Hoʻokō (EU) n. 540/2011 ua hoʻololi ʻia penei:

  • 1. Ma ka ʻāpana A ua holoi ʻia nā mea i kākau ʻia:
    • 1) komo 21 (Cyclanilide);
    • 2) komo 33 (Cynidn-ethyl);
    • 3) komo 43 (Ethoxysulfide);
    • 4) komo 45 (oxadiargyl);
    • 5) komo 49 (Cyfluthrin);
    • 6) komo 56 (Mecoprop);
    • 7) komo 72 (Molinato);
    • 8) komo 87 (Ioxynil);
    • 9) komo 94 (Imazosulfide);
    • 10) komo 100 (tepraloxydim);
    • 11) komo 113 (Maneb);
    • 12) komo 120 (Warfarin);
    • 13) komo 121 (clothianidin);
    • 14) komo 140 (thiamethoxam);
    • 15) komo 143 (Flusilazole);
    • 16) komo 144 (Carbendazime);
    • 17) komo 151 (Glufosinate);
    • 18) komo 157 (Fipronil);
    • 19) komo 174 (Diflubenzurn);
    • 20) komo 175 (Imazaquín);
    • 21) komo 177 (Oxadiazn);
    • 22) komo 184 (Quinoclamine);
    • 23) komo 185 (Chloridazn);
    • 24) komo 190 (Fuberidazole);
    • 25) komo 192 (Daytime);
    • 26) komo i ka 196 [Bacillus thuringiensis subsp. Tenebrionis, kānana Nānā: 176(TM 14 1)];
    • 27) komo 201 (Phlebiopsis gigantea, kānana VRA 1985, VRA 1986, FOC PG B20/5, FOC PG SP log 6, FOC PG SP log 5, FOC PG BU 3, FOC PG BU 4, FOC PG97/1062/116 1.1, FOC PG B22/SP1287/3.1, FOC PG SH 1, FOC PG B22/SP1190/3.2);
    • 28) komo 205 (Trichoderma polysporum, kānana IMI 206039;
    • 29) komo 211 (Epoxiconazole);
    • 30) komo 212 (Fenpropimorph);
    • 31) komo 214 (Tralkoxydim);
    • 32) komo 216 (imidacloprid);
    • 33) komo 221 (Ammonium Acetate);
    • 34) komo 226 (Denatonium Benzoate);
    • 35) komo 237 (Limestone);
    • 36) komo 239 (Pepper dust extraction residues);
    • 37) komo i ka 245 [1,4-diaminobutane (putrescine)];
    • 38) komo i ka 252 [Limu Extract (formerly Seaweed and Seaweed Extract)];
    • 39) komo 253 (Sodium aluminum silicate);
    • 40) komo 254 (Sodium hypochlorite);
    • 41) komo 256 (Trimethylamine hydrochloride);
    • 42) komo 261 (Calcium Phosphide);
    • 43) komo 269 (Triadimenol);
    • 44) komo 270 (Methomyl);
    • 45) komo 280 (Teflubenzurn);
    • 46) komo 281 (Zeta-cypermethrin);
    • 47) komo 282 (chlorosulfide);
    • 48) komo 283 (Cyromazine);
    • 49) komo 286 (Lufenurn);
    • 50) komo 290 (Difenacum);
    • 51) komo 303 (spirodiclofen);
    • 52) komo 306 (Triflumizole);
    • 53) komo i ka 308 [FEN 560 (i kapa ʻia ʻo fenugreek a i ʻole nā ​​​​anoano fenugreek pauda)];
    • 54) komo 309 (Haloxyfop-P);
    • 55) komo 312 (Metosulam);
    • 56) komo 315 (Fenbuconazole);
    • 57) komo 319 (Myclobutanil);
    • 58) komo 321 (Triflumurn);
    • 59) komo 324 (Dietofencarb);
    • 60) komo 325 (Etridiazole);
    • 61) komo 327 (Oryzaline);
    • 62) komo 332 (Fenoxycarb);
    • 63) komo 336 (Carbetamide);
    • 64) komo 337 (Carboxin);
    • 65) komo 338 (Cyproconazole);
    • 66) komo 347 (Bromadiolone);
    • 67) komo 349 (Pencil);
    • 68) komo 353 (Flutriafol);

    LE0000455592_20220519E hele i ka Affected Normal

  • 2. Ma ka ʻāpana B ua holoi ʻia nā mea i kākau ʻia:
    • 1) komo 2 (profoxydim);
    • 2) komo 3 (Azymsulfide);
    • 3) komo 14 (Fluquinconazole);
    • 4) komo 17 (Triazide);
    • 5) komo 19 (Acrinathrin);
    • 6) komo 20 (Prochloraz);
    • 7) komo 23 (Bifenthrin).

    LE0000455592_20220519E hele i ka Affected Normal